201 related articles for article (PubMed ID: 29441847)
1.
Yang Y; Wang W; Xiong Z; Kong J; Wang L; Qiu Y; Shen F; Huang Z
Pharmazie; 2016 Sep; 71(9):514-523. PubMed ID: 29441847
[TBL] [Abstract][Full Text] [Related]
2. Activation of SIRT3 attenuates triptolide-induced toxicity through closing mitochondrial permeability transition pore in cardiomyocytes.
Yang Y; Wang W; Xiong Z; Kong J; Qiu Y; Shen F; Huang Z
Toxicol In Vitro; 2016 Aug; 34():128-137. PubMed ID: 27064125
[TBL] [Abstract][Full Text] [Related]
3. Triptolide induces p53-dependent cardiotoxicity through mitochondrial membrane permeabilization in cardiomyocytes.
Xi Y; Wang W; Wang L; Pan J; Cheng Y; Shen F; Huang Z
Toxicol Appl Pharmacol; 2018 Sep; 355():269-285. PubMed ID: 30009776
[TBL] [Abstract][Full Text] [Related]
4. Triptolide-induced oxidative stress involved with Nrf2 contribute to cardiomyocyte apoptosis through mitochondrial dependent pathways.
Zhou J; Xi C; Wang W; Fu X; Jinqiang L; Qiu Y; Jin J; Xu J; Huang Z
Toxicol Lett; 2014 Nov; 230(3):454-66. PubMed ID: 25169008
[TBL] [Abstract][Full Text] [Related]
5. Autophagy plays an important role in triptolide-induced apoptosis in cardiomyocytes.
Zhou J; Xi C; Wang W; Yang Y; Qiu Y; Huang Z
Toxicol Lett; 2015 Aug; 236(3):168-83. PubMed ID: 26007683
[TBL] [Abstract][Full Text] [Related]
6. Triptolide dysregulates glucose uptake via inhibition of IKKβ-NF-κB pathway by p53 activation in cardiomyocytes.
Xi Y; Zhang Y; Pan J; Chen S; Lu S; Shen F; Huang Z
Toxicol Lett; 2020 Jan; 318():1-11. PubMed ID: 31618665
[TBL] [Abstract][Full Text] [Related]
7. Triptolide induces mitochondria-mediated apoptosis of Burkitt's lymphoma cell via deacetylation of GSK-3β by increased SIRT3 expression.
Kong J; Wang L; Ren L; Yan Y; Cheng Y; Huang Z; Shen F
Toxicol Appl Pharmacol; 2018 Mar; 342():1-13. PubMed ID: 29407771
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of glycogen synthase kinase 3beta ameliorates triptolide-induced acute cardiac injury by desensitizing mitochondrial permeability transition.
Wang W; Yang Y; Xiong Z; Kong J; Fu X; Shen F; Huang Z
Toxicol Appl Pharmacol; 2016 Dec; 313():195-203. PubMed ID: 27751939
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol protects against myocardial ischemic injury in obese mice via activating SIRT3/FOXO3a signaling pathway and restoring redox homeostasis.
Zhu X; Ma E; Ge Y; Yuan M; Guo X; Peng J; Zhu W; Ren DN; Wo D
Biomed Pharmacother; 2024 May; 174():116476. PubMed ID: 38520872
[TBL] [Abstract][Full Text] [Related]
10. Integrated targeted sphingolipidomics and transcriptomics reveal abnormal sphingolipid metabolism as a novel mechanism of the hepatotoxicity and nephrotoxicity of triptolide.
Qu L; Qu F; Jia Z; Wang C; Wu C; Zhang J
J Ethnopharmacol; 2015 Jul; 170():28-38. PubMed ID: 25978956
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA expression, targeting, release dynamics and early-warning biomarkers in acute cardiotoxicity induced by triptolide in rats.
Wang SR; Chen X; Ling S; Ni RZ; Guo H; Xu JW
Biomed Pharmacother; 2019 Mar; 111():1467-1477. PubMed ID: 30841462
[TBL] [Abstract][Full Text] [Related]
12. Role of MicroRNA-155 in Triptolide-induced hepatotoxicity via the Nrf2-Dependent pathway.
Li Y; Guo L; Hou Z; Gong H; Yan M; Zhang B
J Ethnopharmacol; 2021 Dec; 281():114489. PubMed ID: 34363931
[TBL] [Abstract][Full Text] [Related]
13. Triptolide impairs thioredoxin system by suppressing Notch1-mediated PTEN/Akt/Txnip signaling in hepatocytes.
Shen F; Xiong Z; Kong J; Wang L; Cheng Y; Jin J; Huang Z
Toxicol Lett; 2019 Jan; 300():105-115. PubMed ID: 30394310
[TBL] [Abstract][Full Text] [Related]
14. Pinocembrin inhibited cardiomyocyte pyroptosis against doxorubicin-induced cardiac dysfunction via regulating Nrf2/Sirt3 signaling pathway.
Gu J; Huang H; Liu C; Jiang B; Li M; Liu L; Zhang S
Int Immunopharmacol; 2021 Jun; 95():107533. PubMed ID: 33752080
[TBL] [Abstract][Full Text] [Related]
15. Comparison of toxicokinetic and tissue distribution of triptolide-loaded solid lipid nanoparticles vs free triptolide in rats.
Xue M; Zhao Y; Li XJ; Jiang ZZ; Zhang L; Liu SH; Li XM; Zhang LY; Yang SY
Eur J Pharm Sci; 2012 Nov; 47(4):713-7. PubMed ID: 22677813
[TBL] [Abstract][Full Text] [Related]
16. Triptolide induces atrophy of myotubes by triggering IRS-1 degradation and activating the FoxO3 pathway.
Wang J; Gao X; Ren D; Zhang M; Zhang P; Lu S; Huan C; Yao Y; Zheng L; Bao Z; Zhou J
Toxicol In Vitro; 2020 Jun; 65():104793. PubMed ID: 32061799
[TBL] [Abstract][Full Text] [Related]
17. Isoliquiritigenin protects against triptolide-induced hepatotoxicity in mice through Nrf2 activation.
Cao L-; Yan M; Ma YX; Zhang BK; Fang PF; Xiang DX; Li ZH; Gong H; Deng Y; Li HD
Pharmazie; 2016 Jul; 71(7):394-397. PubMed ID: 29441915
[TBL] [Abstract][Full Text] [Related]
18. Quantitative Proteomics and Targeted Fatty Acids Analysis Reveal the Damage of Triptolide in Liver and Kidney.
Li M; Hu T; Tie C; Qu L; Zheng H; Zhang J
Proteomics; 2017 Nov; 17(22):. PubMed ID: 28895652
[TBL] [Abstract][Full Text] [Related]
19. Toxicity of triptolide and the molecular mechanisms involved.
Xi C; Peng S; Wu Z; Zhou Q; Zhou J
Biomed Pharmacother; 2017 Jun; 90():531-541. PubMed ID: 28402922
[TBL] [Abstract][Full Text] [Related]
20. Triptolide induces oxidative damage in NRK-52E cells through facilitating Nrf2 degradation by ubiquitination via the GSK-3β/Fyn pathway.
Pan J; Shen F; Tian K; Wang M; Xi Y; Li J; Huang Z
Toxicol In Vitro; 2019 Aug; 58():187-194. PubMed ID: 30926361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
